Agenus
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agenus and other ETFs, options, and stocks.About AGEN
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777.
CEOGaro H. Armen
CEOGaro H. Armen
Employees389
Employees389
HeadquartersLexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded1994
Founded1994
Employees389
Employees389
AGEN Key Statistics
Market cap111.01M
Market cap111.01M
Price-Earnings ratio-0.38
Price-Earnings ratio-0.38
Dividend yield—
Dividend yield—
Average volume1.16M
Average volume1.16M
High today$5.87
High today$5.87
Low today$4.91
Low today$4.91
Open price$4.96
Open price$4.96
Volume1.46M
Volume1.46M
52 Week high$42.60
52 Week high$42.60
52 Week low$4.78
52 Week low$4.78
AGEN News
TipRanks 5d
Biotech Alert: Searches spiking for these stocks todayThese names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Pipeline and key...
TipRanks 7d
Agenus announces updated results from BOT/BAL combination therapy trial - TipRanks.com - TipRanksAgenus announced updated results from its Phase 1 clinical trial of BOT/BAL combination therapy in patients with metastatic CRC that is not microsatellite insta...